These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 908492)

  • 1. Metabolism of ursodeoxycholic acid in man.
    Fedorowski T; Salen G; Calallilo A; Tint GS; Mosbach EH; Hall JC
    Gastroenterology; 1977 Nov; 73(5):1131-7. PubMed ID: 908492
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
    Salen G; Verga D; Batta AK; Tint GS; Shefer S
    Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids in bile during long-term chenodeoxycholic acid treatment.
    Bremmelgaard A; Pedersen L
    Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 7. The biochemistry of gallstone formation.
    Bouchier IA
    Clin Gastroenterol; 1973 Jan; 2(1):49-66. PubMed ID: 4271976
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
    Thistle JL; Hofmann AF; Yu PY; Ott B
    Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition.
    Su CC; Higuchi WI; Gilmore IT; Danzinger RG; Hofmann AF
    J Pharm Sci; 1984 Aug; 73(8):1160-1. PubMed ID: 6491925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gallbladder in gallstone formation.
    Nakayama F; van der Linden W
    Acta Chir Scand; 1974; 140(1):45-9. PubMed ID: 4819022
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3alpha-hydroxysteroid dehydrogenase.
    Fausa O; Skålhegg BA
    Scand J Gastroenterol; 1974; 9(3):249-54. PubMed ID: 4369100
    [No Abstract]   [Full Text] [Related]  

  • 12. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
    Arnfred T; Pedersen L
    Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 14. Criteria for selection of patients for medical treatment (chenodeoxycholic acid therapy) of gallstones.
    Bruusgaard A; Malver E; Pedersen LR; Schlichting P; Sylvest J
    Scand J Gastroenterol; 1977; 12(1):97-102. PubMed ID: 834976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous qualitative and quantitative analyses of bile acids by mass chromatography.
    Miyazaki H; Ishibashi M; Inoue M; Ito M; Kubodera T
    J Chromatogr; 1974 Nov; 99(0):554-65. PubMed ID: 4421914
    [No Abstract]   [Full Text] [Related]  

  • 17. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stigmasterol as internal standard for simultaneous quantitation of biliary cholesterol and bile acids by gas-liquid chromatography.
    Subbiah MT
    Clin Chim Acta; 1973 Sep; 48(1):19-21. PubMed ID: 4746726
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of chenodeoxycholic acid in the rhesus monkey.
    Dyrszka H; Chen T; Salen G; Mosbach EH
    Gastroenterology; 1975 Aug; 69(2):333-7. PubMed ID: 1150041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of disturbances in the enterohepatic circulation of bile acids in man: the cholanopathies.
    van Berge Henegouwen GP; Hofmann AF
    Neth J Med; 1978; 21(6):257-69. PubMed ID: 366443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.